These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37097101)

  • 1. Postexposure prophylaxis (PEP) of HIV among adults.
    El Hussein MT; Malyshev I
    Nurse Pract; 2023 May; 48(5):39-47. PubMed ID: 37097101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review.
    Ford N; Shubber Z; Calmy A; Irvine C; Rapparini C; Ajose O; Beanland RL; Vitoria M; Doherty M; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S170-6. PubMed ID: 25972499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.
    Mayer KH; Jones D; Oldenburg C; Jain S; Gelman M; Zaslow S; Grasso C; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):535-539. PubMed ID: 28696345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
    Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive summary of the consensus document on post-exposure prophylaxis against HIV, HBV and HCV in adults and children.
    ; ; ; ; ; ; ; ; ; ; ; Polo Rodriguez R; Lozano F; González de Castro P; Jiménez MA; Miró O; Ramón Blanco J; Moreno D; Dueñas C; Muñoz Platón E; Fernández Escribano M; Sanz Sanz J; Fumaz C; Santos I; García F; Téllez MJ; González Montero R; Vals Jimenez MV; Losa J; Valle Robles ML; Iribarren J; Ortega E
    Enferm Infecc Microbiol Clin; 2016 Feb; 34(2):122-31. PubMed ID: 26474709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Nortey PA; Dodoo AN
    BMC Public Health; 2015 Jun; 15():573. PubMed ID: 26092496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies.
    Irvine C; Egan KJ; Shubber Z; Van Rompay KK; Beanland RL; Ford N
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S165-9. PubMed ID: 25972498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. World Health Organization Guidelines on Postexposure Prophylaxis for HIV: Recommendations for a Public Health Approach.
    Ford N; Mayer KH;
    Clin Infect Dis; 2015 Jun; 60 Suppl 3():S161-4. PubMed ID: 25972497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission.
    Weber J; Tatoud R; Fidler S
    AIDS; 2010 Oct; 24 Suppl 4():S27-39. PubMed ID: 21042050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping HIV prevention strategies; case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men.
    Smith DE; Gardiner J; Oliver R; Fagan D
    Sex Transm Infect; 2017 Jun; 93(4):238-239. PubMed ID: 25795661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postexposure prophylaxis after sexual exposure to HIV.
    Roland ME
    Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-exposure prophylaxis for HIV infection.
    Rey D
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):431-42. PubMed ID: 21504400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.